Indeed , percent reduction over PBO in baseline-adjusted focal seizure frequency/week ( primary efficacy analysis ) was @ % ( p = @ ) , @ % ( p = @ ) , and @ % ( p = @ ) for BRV @ , @ , and @ mg/day , respectively .